Furthermore, axonal degeneration, a precursor to numerous neurodegenerative diseases, is closely linked to a rapid decline in NAD+ levels, attributed to decreased expression of the NAD+ biosynthetic enzyme nicotinamide mononucleotide adenylyl transferase 2 (NMNAT2). This evidence concerns the gene NMNAT2 and neurodegenerative disease.